One-year results of reduced fluence photodynamic therapy for central serous chorioretinopathy: the outer nuclear layer thickness is associated with visual prognosis

[1]  Lawrence A. Yannuzzi,et al.  INDOCYANINE GREEN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY FOR TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: A Pilot Study , 2012, Retina.

[2]  J. Ruiz-Moreno,et al.  Retinal thickness changes following photodynamic therapy in chronic central serous chorioretinopathy , 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.

[3]  Tomohiro Iida,et al.  ONE-YEAR CHOROIDAL THICKNESS RESULTS AFTER PHOTODYNAMIC THERAPY FOR CENTRAL SEROUS CHORIORETINOPATHY , 2011, Retina.

[4]  H. Ozdemir,et al.  Microperimetric changes after photodynamic therapy for central serous chorioretinopathy. , 2011, American journal of ophthalmology.

[5]  K. Park,et al.  COMPARISON OF EFFICACY AND SAFETY BETWEEN HALF-FLUENCE AND FULL-FLUENCE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2011, Retina.

[6]  F. Boscia,et al.  Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial. , 2010, American journal of ophthalmology.

[7]  S. Kishi,et al.  Outer nuclear layer thickness at the fovea determines visual outcomes in resolved central serous chorioretinopathy. , 2009, American journal of ophthalmology.

[8]  Hum Chung,et al.  Prognostic factors related to photodynamic therapy for central serous chorioretinopathy , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  Y Mitamura,et al.  Correlation between visual function and photoreceptor inner/outer segment junction in patients with retinitis pigmentosa , 2009, Eye.

[10]  T. Lai,et al.  Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. , 2008, Ophthalmology.

[11]  Kazuaki Miyamoto,et al.  Foveal photoreceptor layer in eyes with persistent cystoid macular edema associated with branch retinal vein occlusion. , 2008, American journal of ophthalmology.

[12]  T. Lai,et al.  SAFETY ENHANCED PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY: One-Year Results of a Prospective Study , 2008, Retina.

[13]  Haitao Li,et al.  Safety enhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: a short term pilot study , 2006, British Journal of Ophthalmology.

[14]  J. Duker,et al.  Ultrahigh-resolution optical coherence tomography in patients with decreased visual acuity after retinal detachment repair. , 2006, Ophthalmology.

[15]  M. Colucciello.  Choroidal neovascularization complicating photodynamic therapy for central serous retinopathy. , 2006, Retina.

[16]  Michael D. Ober,et al.  Photodynamic therapy for focal retinal pigment epithelial leaks secondary to central serous chorioretinopathy. , 2005, Ophthalmology.

[17]  D. Boyer,et al.  Chronic central serous chorioretinopathy: photodynamic therapy. , 2004, American journal of ophthalmology.

[18]  T. Lai,et al.  Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level , 2003, The British journal of ophthalmology.

[19]  C. Eandi,et al.  Photodynamic Therapy for Chronic Central Serous Chorioretinopathy , 2003, Retina.

[20]  L. Yannuzzi,et al.  CYSTOID MACULAR DEGENERATION IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY , 2003, Retina.

[21]  M. Larsen,et al.  Retinal atrophy in idiopathic central serous chorioretinopathy. , 2002, American journal of ophthalmology.

[22]  Timothy G Murray,et al.  FACTORS ASSOCIATED WITH REDUCED VISUAL ACUITY DURING LONG-TERM FOLLOW-UP OF PATIENTS WITH IDIOPATHIC CENTRAL SEROUS CHORIORETINOPATHY , 2002, Retina.

[23]  G. Virgili,et al.  Indocyanine green angiography in central serous chorioretinopathy , 1997, International Ophthalmology.

[24]  A. Ho,et al.  Digital indocyanine green videoangiography of central serous chorioretinopathy , 1994 .

[25]  J. Slakter,et al.  Laser Treatment of Diffuse Retinal Pigment Epitheliopathy , 1992, European journal of ophthalmology.

[26]  L. Ficker,et al.  Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy. , 1988, The British journal of ophthalmology.

[27]  D. Ilstrup,et al.  Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. , 1983, American journal of ophthalmology.

[28]  P. Leaver,et al.  Argon laser photocoagulation in the treatment of central serous retinopathy. , 1979, The British journal of ophthalmology.

[29]  E. Gragoudas,et al.  Experience with nontreatment of central serous choroidopathy. , 1974, Archives of ophthalmology.

[30]  J D Gass,et al.  Pathogenesis of disciform detachment of the neuroepithelium. , 1967, American journal of ophthalmology.

[31]  S. Kishi,et al.  Elongation of photoreceptor outer segment in central serous chorioretinopathy. , 2008, American journal of ophthalmology.

[32]  G. Ravera,et al.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. , 2005, American journal of ophthalmology.

[33]  C. Prünte.  Indocyanine green angiographic findings in central serous chorioretinopathy , 2004, International Ophthalmology.

[34]  S. Kishi,et al.  Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. , 1999, Retina.

[35]  J. Slakter,et al.  INDOCYANINE GREEN VIDEOANGIOGRAPHY OF OLDER PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY , 1996, Retina.

[36]  F C Piccolino,et al.  CENTRAL SEROUS CHORIORETINOPATHY AND INDOCYANINE GREEN ANGIOGRAPHY , 1994, Retina.

[37]  O. Lund,et al.  Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. , 1993, American journal of ophthalmology.